Teva Pharmaceutical Industries Ltd

Latest stories

6d
Reuters
West Virginia investigating Mylan over EpiPen pricingand bee stings. Morrissey said in Tuesday's petition that Mylan may have viola
West Virginia investigating Mylan over EpiPen pricing
Reuters / Posted 6 days ago
and bee stings. Morrissey said in Tuesday's petition that Mylan may have violated the state's Antitrust Act by suing Teva Pharmaceutical Industries Ltd for patent infringement to prevent it from launching a generic competitor to the... Read more
8 related stories
6d
Channel NewsAsia
West Virginia investigating Mylan over EpiPen pricingand bee stings. Morrissey said in Tuesday's petition that Mylan may have viola
West Virginia investigating Mylan over EpiPen pricing
Channel NewsAsia / Posted 6 days ago
and bee stings. Morrissey said in Tuesday's petition that Mylan may have violated the state's Antitrust Act by suing Teva Pharmaceutical Industries Ltd for patent infringement to prevent it from launching a generic competitor to the... Read more
8 related stories
6d
Raw Story
West Virginia investigating Mylan over EpiPen pricingand bee stings.Morrissey said in Tuesday’s petition that Mylan may have violate
West Virginia investigating Mylan over EpiPen pricing
Raw Story / Posted 6 days ago
and bee stings.Morrissey said in Tuesday’s petition that Mylan may have violated the state’s Antitrust Act by suing Teva Pharmaceutical Industries Ltd for patent infringement to prevent it from launching a generic competitor to the... Read more
17 related stories
6d
Reuters
West Virginia investigating Mylan over EpiPen pricingand bee stings. Morrissey said in Tuesday's petition that Mylan may have viola
West Virginia investigating Mylan over EpiPen pricing
Reuters / Posted 6 days ago
and bee stings. Morrissey said in Tuesday's petition that Mylan may have violated the state's Antitrust Act by suing Teva Pharmaceutical Industries Ltd (TEVA.TA) for patent infringement to prevent it from launching a generic competitor to the... Read more
17 related stories
6d
Reuters
Allergan pays top dollar for 'stepping stones' from neurology to dermatologynow has the money to embark on a major acquisition spree thanks to the sale of
Allergan pays top dollar for 'stepping stones' from neurology to dermatology
Reuters / Posted 6 days ago
now has the money to embark on a major acquisition spree thanks to the sale of its generic drug portfolio to Teva Pharmaceutical Industries Ltd (TEVA.TA). Allergan received $33.4 billion in cash and $5.1 billion in Teva stock last... Read more
6d
Channel NewsAsia
Allergan pays top dollar for 'stepping stones' from neurology to dermatologynow has the money to embark on a major acquisition spree thanks to the sale of
Allergan pays top dollar for 'stepping stones' from neurology to dermatology
Channel NewsAsia / Posted 6 days ago
now has the money to embark on a major acquisition spree thanks to the sale of its generic drug portfolio to Teva Pharmaceutical Industries Ltd . Allergan received US$33.4 billion in cash and US$5.1 billion in Teva stock last month as... Read more
11d
Business Wire
Global Injectable Drug Delivery Market Research and Analysis 2015- Growing Prevalence and Incidence of Chronic Diseases Present Market OpportunitiesPharmaceuticals Plc - Lifelong Meditech Ltd. - Novartis - Pfizer Injectables
Global Injectable Drug Delivery Market Research and Analysis 2015- Growing Prevalence and Incidence of Chronic Diseases Present Market Opportunities
Business Wire / Posted 11 days ago
Pharmaceuticals Plc - Lifelong Meditech Ltd. - Novartis - Pfizer Injectables (Pfizer Inc.) - Sandoz - Schott Ag - Shl Group - Terumo Corporation - Teva Pharmaceutical Industries Ltd - Troikaa Pharmaceuticals Ltd. - Weigao Group - Y... Read more
11d
The Globe and Mail
Teva, Intel to develop wearable technology for Huntington’s diseaseTeva Pharmaceutical Industries Ltd said on Thursday it was collaborating with I
Teva, Intel to develop wearable technology for Huntington’s disease
The Globe and Mail / Posted 11 days ago
Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable technology platform to track the progression of disease in patients with Huntington’s, a fatal degenerative disorder. The inherited... Read more
3 related stories
11d
Reuters
Teva, Intel to develop wearables to monitor Huntington's diseasePharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD
Teva, Intel to develop wearables to monitor Huntington's disease
Reuters / Posted 11 days ago
Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. REUTERS/Ronen Zvulun Teva Pharmaceutical Industries Ltd (TEVA.TA) said on Thursday it was collaborating with Intel Corp (INTC.O) to develop a... Read more
3 related stories
17d
Reuters
Teva says aims to launch EpiPen-like device by 2018 in U.S.company for use by severe allergy sufferers are seen in Washington, U.S. August
Teva says aims to launch EpiPen-like device by 2018 in U.S.
Reuters / Posted 17 days ago
company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo Teva Pharmaceutical Industries Ltd (TEVA.TA) said Friday it aims to win U.S. approval by late 2017 or early 2018 for its... Read more
17d
FOX News
Teva says hoping to launch EpiPen-like device by 2018 in USTeva Pharmaceutical Industries Ltd said Friday it hoped to win U.S. approval by
Teva says hoping to launch EpiPen-like device by 2018 in US
FOX News / Posted 17 days ago
Teva Pharmaceutical Industries Ltd said Friday it hoped to win U.S. approval by late 2017 or early 2018 for its version of Mylan NV's EpiPen device for treating severe allergic reactions, a move that would challenge the branded product's overwhelming... Read more
28d
Bangor Daily News
Mylan to launch generic EpiPen at half the price of originalanalysts said the biggest potential threat to EpiPen is a similar device being
Mylan to launch generic EpiPen at half the price of original
Bangor Daily News / Posted 28 days ago
analysts said the biggest potential threat to EpiPen is a similar device being developed by rival generic drugmaker Teva Pharmaceutical Industries Ltd. The U.S. Food and Drug Administration in February declined to approve the product... Read more
320 related stories
29d
Newsmax
Mylan to Sell Generic EpiPen for Half the Price of Originalrejected Adamis Pharmaceuticals Corp's rival treatment to EpiPen in June. Sanof
Mylan to Sell Generic EpiPen for Half the Price of Original
Newsmax / Posted 29 days ago
rejected Adamis Pharmaceuticals Corp's rival treatment to EpiPen in June. Sanofi has pulled its device from the market and Teva Pharmaceutical Industries Ltd was forced to delay the launch of its version. Mylan is the latest company to be caught... Read more
17 related stories
29d
Newsmax
Mylan to Launch Generic EpiPen After Outcry Over Price Gougingrejected Adamis Pharmaceuticals Corp's rival treatment to EpiPen in June. Sanof
Mylan to Launch Generic EpiPen After Outcry Over Price Gouging
Newsmax / Posted 29 days ago
rejected Adamis Pharmaceuticals Corp's rival treatment to EpiPen in June. Sanofi has pulled its device from the market and Teva Pharmaceutical Industries Ltd was forced to delay the launch of its version. Mylan is the latest company to be caught... Read more
17 related stories
30d
Zero Hedge
The EpiPen Scandal Is Worse Than You Think: What You’re Not Being ToldDrives Prices Down — And Mylan Wasn’t Down with That In 2009, Pfizer Inc., the
The EpiPen Scandal Is Worse Than You Think: What You’re Not Being Told
Zero Hedge / Posted 30 days ago
Drives Prices Down — And Mylan Wasn’t Down with That In 2009, Pfizer Inc., the world’s biggest drugmaker, and Mylan sued Teva Pharmaceutical Industries Ltd. over a patent-infringement. At the time, the Israeli company was accused of using Mylan’s... Read more
480 related stories
m
The Register NorthJersey.com
Anger over EpiPen prompts offer of $300 discount from drugmakerearlier this year, the FDA found “major deficiencies” in a quest for a competin
Anger over EpiPen prompts offer of $300 discount from drugmaker
The Register NorthJersey.com / Posted 1 months ago
earlier this year, the FDA found “major deficiencies” in a quest for a competing generic version of the EpiPen produced by Teva Pharmaceutical Industries Ltd. It is delayed until at least 2017. State Sen. Richard Codey, D-Essex, who wrote a letter... Read more
480 related stories
m
Market Watch
After Mylan uproar, a generic EpiPen could hit the market in 2017on Mylan may push the FDA to accelerate applications for generic versions of th
After Mylan uproar, a generic EpiPen could hit the market in 2017
Market Watch / Posted 1 months ago
on Mylan may push the FDA to accelerate applications for generic versions of the drug, with most of the hope resting on Teva Pharmaceutical Industries Ltd. TEVA, +0.04% “We suspect the FDA will be under pressure to enable a more competitive... Read more
31 related stories
m
Newsmax
Hillary Clinton's Attacks on Drug Prices Leave Health Stocks Reeling& Co. in New York. He mostly blamed the dip after Clinton’s statement to sensit
Hillary Clinton's Attacks on Drug Prices Leave Health Stocks Reeling
Newsmax / Posted 1 months ago
& Co. in New York. He mostly blamed the dip after Clinton’s statement to sensitivity surrounding health stocks generally. Teva Pharmaceutical Industries Ltd. is also working on a generic competitor that could benefit from a sped-up review as a... Read more
480 related stories

People in this news